Maybe Don could weigh in. What does this mean for Pona? Certainly worth more but what? I have no idea but I do know this will change the future. So what do you think Don, what diseases are we talking about, what is the market for an FGFR inhibitor?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.